The Centers for Medicare and Medicaid Services has put at least one of the controversial elements of a pending Medicaid pricing rule on hold.
CMS Proposal To Further Reduce Medicaid 'Best Prices' Thwarted, For Now
The agency says it will collect additional information from manufacturers on methods for adding up price concessions from the supply chain before moving ahead.
More from Market Access
More from Pink Sheet
• By
Experts say PBMs should become familiar with transparency rules and prepare to release data, although more legal wrangling could occur.
• By
Optum Rx, one of the largest PBMs in the US, declared it was the “first comprehensive, transparent pharmacy services company” after announcing several consumer-friendly changes.
• By
FDA Commissioner Martin Makary was sworn in Friday and knew of the plan that ultimately lead to CBER director Peter Marks' resignation on 28 March.